Verified Events
DateTypeCompanyHeadlineSegment
Intuitive da Vinci SP used in four-part breast surgery at MedStar Georgetown
- The patient was a 50-year-old woman with early-stage breast cancer.
- The approach is intended for selected patients with small to moderate breast size, a healthy body weight and appropriately positioned nipples.
XCath’s Iris surgical robot enters FDA TAP programme
- Enrollment follows Iris’s September 2, 2026 Breakthrough Device designation.
- A dedicated FDA advisor and review-team engagement will cover development decisions, with facilitated input from payers, providers and other stakeholders.
- Iris remains under development and is not cleared for commercial distribution in any country.
MMI raises $125 million Series D for Symani commercial expansion
- Approximately 50 Symani systems are installed, with 3,500 complex microsurgical procedures performed worldwide.
- Proceeds support expansion in the United States and other markets, clinical evidence including REMIND, and energy-instrument and digital-surgery development.
Redefine Surgery closes oversubscribed pre-seed financing
- The company described the investor base as predominantly surgeons.
- Proceeds support development of its portable surgical-intelligence platform ahead of commercialization.
- Its initial orthopedic focus includes computer-vision guidance and robotic assistance; the platform remains under development and subject to clearance.
Intuitive introduces da Vinci 5 in India
- Da Vinci 5 includes more than 150 design enhancements over da Vinci Xi, including Force Feedback instruments and expanded integrated workflows.
- The system provides 10,000 times the computing power of the previous generation to support analytics, connected learning and future software capabilities.
- Surgeons in India have performed more than 200,000 procedures using da Vinci systems, according to Intuitive.
MMI receives €17M EIB–Angelini Ventures co-investment
- The financing is the third completed investment under the investors’ €150M European life-sciences programme.
- MMI manufactures the Symani system in Pisa for microsurgery and super-microsurgery.
- EIB and Angelini Ventures each committed €75M to the six-year co-investment programme, which targets 7–10 European companies.
HOPE begins training for deployment of Zeta TMS Robotic System
- HOPE is the first interventional-psychiatry network preparing to deploy the robotic system.
- The system mounts the TMS coil on a robotic arm and adjusts its position as the patient moves.
- The rollout is separate from HOPE’s earlier use of Zeta’s non-robotic TMS Navigation System.
Intuitive da Vinci 5 selected in $2.96M VA delivery order
- The firm-fixed-price order, 36C24726F0321, was awarded to SDV Office Systems LLC, which does business as SDV Medical.
- The $2,956,840 ceiling is fully obligated under parent contract 36C10G25D0013.
- The federal record identifies the purchased system as a da Vinci DV5 surgical robot and schedules performance from September 14 through December 14, 2026.
Parallel Robotics discloses $7.31M equity financing in Form D
- The filing identifies August 28, 2026 as the date of first sale.
- The $11.31M figure is the total offering amount, not capital raised; the recorded round amount is $7.31M sold.
- The filing does not identify a Series A label or name participating investors, so neither is inferred.
Johnson & Johnson launches MONARCH QUEST 3 navigation update
- QUEST 3 adds AI-powered nodule segmentation and navigation enhancements designed to account for anatomical shift.
- The update adds a 3D Compass orientation overlay and broader compatibility with mobile and fixed cone-beam CT systems.
- Polyphonic integration adds centralized procedural-video review and collaboration tools.
SS Innovations reports record Q2 revenue and 224-system installed base
- Revenue reached $13.9 million, up 39.4% from the prior-year quarter.
- The company installed 30 SSi Mantra systems during the quarter, taking the cumulative installed base to 224 systems across 12 countries.
- Cumulative procedures performed with the platform reached 12,272.
Noah Medical commercially launches Galaxy II bronchoscopy software
- Physicians can switch between high-definition digital tomosynthesis and cone-beam CT during a procedure without moving to a separate platform.
- The update combines navigation with real-time lesion and tool confirmation to address CT-to-body and tool-tissue divergence.
- Noah cites published literature indicating that HD-DT can support most cases with up to ten times lower radiation dose than CBCT.
Stereotaxis reports first GenesisX U.S. purchase and catheter growth
- Quarterly revenue from the company's robotic catheters exceeded $1 million, up 270% sequentially.
- A U.S. hospital placed the first GenesisX purchase, with installation planned for autumn 2026.
- Multiple Synchrony digital operating-room systems were sold and installed after FDA clearance in April.
PROCEPT BioRobotics reports $94.5 million Q2 revenue
- The company delivered 65 HYDROS systems during the quarter.
- U.S. procedure volume exceeded 13,100, representing 21% year-on-year growth.
- PROCEPT maintained full-year revenue guidance of $390 million to $410 million.
Andromeda Surgical raises $15M Series A for surgical robotics
- Phaze Ventures identifies Y Combinator, Lingotto Innovation and Alumni Ventures among participating investors; the founder announcement also names VOX Capital.
- The company reports $30 million total funding; valuation and exact closing date were not disclosed.
- Clinical procedures and a proposed commercial launch remain distinct; regulatory-status reports conflict and no new approval or commercial deployment is inferred.
MMI receives FDA approval to expand REMIND microsurgery study
- The supplement followed FDA review of 30-day safety data from the first patient cohort.
- REMIND evaluates Symani-enabled microsurgical techniques intended to re-establish deep-cervical lymphatic drainage in patients with Alzheimer's disease and confirmed lymphatic abnormalities.
- The study remains an early-feasibility investigation; Symani is not FDA-cleared for lymphatic reconstruction for brain disease.
Cleveland Clinic Abu Dhabi completes Middle East's first MONARCH robotic bronchoscopy
- MONARCH guides a flexible endoscope through the lung airways to biopsy small, hard-to-reach nodules.
- The completed procedure establishes clinical use at Cleveland Clinic Abu Dhabi.
- The hospital used the platform to support continuous-vision navigation and tissue sampling in peripheral lung anatomy.
FDA clears updated MONARCH Platform configuration
- The applicant is Auris Health, Inc. at its Santa Clara operating address.
- The filing covers MONARCH Platform configuration MON-000008.
- The FDA decision date was 25 July 2026.
OTTAVA receives US FDA De Novo authorization
- Authorization covers multiple upper-abdominal general-surgery procedures.
- OTTAVA coordinates four table-integrated robotic arms with synchronized table motion.
- A 30-patient pivotal gastric-bypass study completed every procedure robotically without conversion.
Vicarious Surgical shareholders approve dissolution and liquidation
- The shareholder vote followed the board's June proposal to cease operations and wind down the surgical-robotics developer.
- Substantially all assets were assigned to Vicarious Liquidation LLC for liquidation and creditor settlement.
- MassDevice and related securities filings reported the termination of senior executives after the approval.
Genesis treats first patients at Hungary's University of Szeged
- The Szent-Györgyi Albert Clinical Center is the first hospital in Hungary to establish a heart-rhythm programme using Genesis RMN.
- Physicians have treated the programme's first patients across a broad range of cardiac arrhythmias.
- Genesis uses computer-controlled magnetic fields to steer compatible interventional devices during catheter-based procedures.
Zeta adds FDA-cleared robotic positioning to its TMS platform
- Robotic positioning dynamically tracks patient movement and adjusts the TMS coil to maintain alignment.
- The system was described as providing submillimeter-level positioning accuracy and setup in under a minute.
- Accuracy and usability testing involved Harvard Medical School and the University of Cambridge.
Parallel Robotics receives $305,000 NSF SBIR Phase I award
- Contract 2507711 runs from July 6 through December 31, 2026.
- The work covers preclinical prototype fabrication, mechatronic and software development, and surgeon evaluation in a simulated environment.
- The award supports technical feasibility work and does not establish commercial availability or regulatory clearance.
Microbot Medical adds Sanmina manufacturing capacity for LIBERTY
- Microbot framed the Sanmina agreement as a second manufacturing site and capacity expansion.
- LIBERTY is an FDA-cleared, single-use robotic system for remote endovascular procedures.
Microbot Medical expands LIBERTY commercial footprint to seven Eastern U.S. states
- Microbot said the system spans multiple hospitals and specialty centers serving Pennsylvania and New Jersey.
- The company said LIBERTY now has accounts across seven Eastern U.S. states.
First patient treated with Zeta TMS Navigation System at HOPE Therapeutics
- Navigation systems were installed in West Palm Beach and Sarasota, with treatments beginning at both clinics that week.
- RealTrack registers MRI or CT images to facial anatomy in under two minutes and continuously tracks the TMS coil.
- Outpatient workflows included eligible patients receiving treatment for major depressive disorder.
Channel Robotics closes $2.5M Seed+ round, taking total funding to $4.6M
- The financing brings Channel Robotics to $4.6 million in total capital raised.
- The company is developing a handheld endoscopic robotic platform for physician use.
- Proceeds support product development, regulatory work and commercialization preparation.
Microbot Medical adds first Michigan LIBERTY healthcare-system customer
- Microbot Medical announced the first Michigan healthcare-system adoption of its LIBERTY endovascular robotic system.
- The company described the customer as one of Michigan’s largest healthcare systems.
- The adoption followed North Carolina expansion and supported LIBERTY’s Midwest commercial rollout.
Noah Medical appoints Krish Bhadra Chief Pulmonary Advisor
- Bhadra has performed more than 2,300 robotic-assisted bronchoscopy procedures and works at Stanford Medicine.
- He trained at the University of Pennsylvania and University of Vermont and earned his medical degree at the University of Miami.
Microbot Medical secures first North Carolina LIBERTY customer
- The company said the account broadened LIBERTY penetration across the Southeast, Mid-Atlantic and Northeast U.S.
- The customer was described as a leading academic center with a multi-hospital network.
Microbot Medical receives first international LIBERTY marketing approval
- Israel became the second jurisdiction, after the U.S., to clear LIBERTY for marketing.
- The AMAR approval supports commercialization in Israel and a Free Sale Certificate for additional submissions.
- The approval supports Microbot Medical's path toward fielded use in maritime autonomy, underwater robotics or marine inspection workflows.
Zeta Surgical begins first commercial TMS Navigation deployment at HOPE Therapeutics
- RealTrack uses markerless image guidance to align MRI or CT scans with patient facial anatomy.
- The system was described as providing submillimetric precision with session setup under two minutes.
- The clinic planned to use navigated TMS for major depressive disorder and other neurological conditions.
Microbot Medical reports multiple LIBERTY account wins after full release
- The company said new accounts included two ACCESS-PVI pivotal clinical trial sites.
- The announcement framed commercial adoption as validation of LIBERTY in everyday practice.
Zeta Surgical receives FDA clearance for cranial navigation and instruments
- The instruments provide navigated guidance for catheter and shunt placement, brain biopsies and trigeminal rhizotomies.
- CT or MRI scans are aligned with patient anatomy using computer vision and artificial intelligence.
- A large commercial pilot with the Big 10 Neurosurgical Consortium was planned for 2026.
Neuralink details surgical robot automation for implant procedure
- Neuralink published a video describing its surgical robot work for automating key steps in receiving a Neuralink implant.
- The company framed the robot as improving safety, reliability, and scalability for implant procedures.
- The update reinforces the R1 surgical robot as a core enabling system for Neuralink's clinical BCI platform rather than a standalone surgical robot product.
Neuralink participant controls robotic arm through CONVOY study
- Alex Conley, the second Neuralink participant, used the N1 Implant to control a robotic arm at Barrow Neurological Institute.
- The robotic arm work is part of Neuralink's CONVOY study, which explores BCI control of assistive devices in real-world use.
- The update marks Neuralink's clearest recent robotics milestone beyond digital cursor control, but it remains a clinical feasibility study rather than a commercial assistive-robot deployment.
XCath Iris completes first in-human telerobotic stroke procedure
- Dr. Vitor Mendes Pereira operated from a control room in Santiago, Panama, about 200 kilometres from the patient at Panama Clinic in Panama City.
- The procedure was overseen locally by principal investigator Dr. Anastasio Ameijeiras Sibauste and used remote robotic mechanical thrombectomy for an ischemic stroke.
- Crescent Enterprises reported submillimetre precision, no perceptible latency and successful treatment in the landmark remote intervention.
Zeta Surgical and NRx advance robotic-enabled TMS programme
- The initiative combines D-cycloserine neuroplastic therapy with TMS under robotic-enabled neuronavigation.
- Development is organized through NRx Defense Systems, a newly incorporated Florida research and development subsidiary.
- NRx named retired U.S. Navy captain Dr. Dennis McBride as the subsidiary’s first president.
XCath secures $30M Series C to advance neuro-endovascular surgical robotics
- XCath announced a $30M Series C to support development and future commercialization of its endovascular surgical robot.
- The round was co-led by Crescent Enterprises and Dr. Fred Moll, chairman of XCath's board.
- The financing brought total capital raised since the company's 2017 founding to $92M.
SS Innovations raises $18.6M private placement to expand surgical robotics globally
- SS Innovations disclosed an $18.6M private placement to support global sales of its SSI Mantra surgical robotic system.
- Proceeds are intended to support growth in India while preparing for market entry in the United States and European Union.
- The company had filed for FDA 510(k) clearance in December, with U.S. review expected to progress through 2026.
Intuitive acquires da Vinci and Ion distribution businesses in Southern Europe
- Intuitive completed the acquisition of da Vinci and Ion distribution businesses covering Italy, Spain, Portugal, Malta, San Marino, and associated territories.
- The transaction expands Intuitive's direct commercial operations in Southern Europe and adds approximately 250 employees to its regional commercial and marketing organization.
- Intuitive said the acquired markets had a combined installed base of more than 470 da Vinci systems as of December 31, 2025, while Ion had recently launched in Italy and Spain.
Channel Robotics raises $1.61M to develop surgical robotics platform
- Funding supports development of robotic system for minimally invasive surgical procedures
- Backed by Old Line Capital Partners
- Targets improved precision and efficiency in endoscopic workflows
Johnson & Johnson submits OTTAVA robotic surgical system to FDA
- Johnson & Johnson MedTech submitted the OTTAVA robotic surgical system to the U.S. FDA.
- The submission was supported by data from the system's investigational device exemption study.
- The event marks a regulatory milestone after first clinical cases were completed in 2025.
Neocis reports 100,000 Yomi robotic osteotomies and first Yomi S cases
- The milestone covered cumulative real-world use of the Yomi platform across implant indications and practice settings.
- Neocis said Dr. Jay Neugarten completed the first successful clinical cases with Yomi S.
Stereotaxis receives FDA approval for MAGiC ablation catheter
- The FDA approval covered the MAGiC Magnetic Interventional Ablation Catheter.
- MAGiC is navigated by computer-controlled magnetic fields.
- The catheter is designed for cardiac ablation procedures that treat heart arrhythmia.
Neuralink targets high-volume implant production and automated surgical procedures
- Neuralink targeted high-volume production of its brain-computer interface devices beginning in 2026.
- The same report described a planned transition toward fully automated surgical implantation procedures.
- The update links Neuralink's implant scale-up to automation around a robot-assisted medical workflow.
SS Innovations performs 24 telesurgeries in 12 hours and reaches 100th telesurgery milestone
- Surgeons using SSI Mantra completed 24 telesurgeries in 12 hours from SS Innovations headquarters.
- The initiative coincided with the company's 100th telesurgery milestone.
- The event served as a scaled deployment proof point for the firm's remote surgery infrastructure.
Empyrean Medical Systems partners with Thrive Pet Healthcare on Sirius veterinary radiation platform
- Empyrean Medical Systems and Thrive Pet Healthcare announced a strategic partnership to bring the Sirius robotically accelerated conformal-beam radiation platform to veterinary oncology.
- The first Sirius system is planned for PetCure Oncology at the Veterinary Specialty Center of Seattle, with the site expected to open in early 2026.
- Empyrean describes Sirius as a photon-augmented stereotactic radiation system that combines robotic precision, treatment planning, and real-time image guidance for targeted veterinary care.
Neocis unveils Yomi S dental surgery robot and YomiPlan AI
- Yomi S launched with a smaller footprint, improved dexterity, better visibility and single-practitioner workflow controls.
- YomiPlan added AI-assisted preoperative planning tools for segmentation and implant-procedure workflow support.
- Neocis announced Yomi S as its second-generation robotic dental surgery system after FDA 510(k) clearance.
XCath EVR robotic system performs first-in-human brain aneurysm procedures
- XCath announced first-in-human use of its EVR robotic system to treat three patients with complex brain aneurysms at The Panama Clinic.
- The procedures marked only the second time a surgical robot had been used in an intracranial neurovascular intervention.
- The milestone established a major clinical proof point ahead of commercialization and later Series C financing.
Microbot Medical starts U.S. limited market release for LIBERTY
- LIBERTY became commercially available in the U.S. through selected high-procedure-volume regions.
- The company said the launch followed commercial-team hiring and a third-party logistics partnership.
- The product gives The company a concrete offering for warehouse automation and material-handling workflows.
Surgical Automations announces $3.4M seed round
- Surgical Automations announced the $3.4 million seed round on October 30, 2025 and said it had closed earlier that year.
- Intuitive Surgical founder Fred Moll and cross-border venture firm TurboStart co-led the financing, joined by physicians and individual community investors.
- The company is using the backing to advance Vasuki toward preclinical validation and first-in-human studies for upper and lower gastrointestinal procedures.
Zeta TMS Navigation System receives FDA 510(k) clearance
- Three-dimensional imaging and motion-aware tracking support coil alignment to planned brain targets during patient movement.
- The device is classified as a Class II stereotaxic instrument under 21 CFR 882.4560 and product codes SGE and QFF.
- Testing with Cambridge and Harvard collaborators reported sub-millimeter translational and sub-degree angular precision in bench, phantom and cadaver settings.
Remedy Robotics raises $35M Series A to scale remote surgical robotics platform
- Named investors or backers include DCVC, Blackbird Ventures.
- The financing supports continued development, regulatory progress, or deployment of healthcare robotics systems.
Remedy Robotics Introduces N1 System, Completes First Fully Remote Neurointerventional Procedures
- • Remedy Robotics introduced the N1 System, a remotely operable endovascular robotic platform.
- • Dr. Vitor Mendes Pereira performed the world's first fully remote neurointerventional procedures using the N1 System between St. Michael'...
- • These procedures were conducted entirely robotically and remotely, with no bedside interventionist present.
Doctors in Toronto complete distant brain angiograms using the N1 system from Remedy Robotics
- Remedy Robotics completed the world's first fully remote neurointerventional procedures using the N1 System.
- Dr. Vitor Mendes Pereira performed these procedures remotely from St. Joseph's Health Centre on patients located at St. Michael's Hospital in Toronto.
- The procedures were conducted without a bedside interventionist, marking a groundbreaking first for the field.
AiM Medical Robotics closes $8.1 million Series A
- IQ Capital, 1540 Ventures and Worcester Polytechnic Institute were among the institutional investors.
- Sontag Innovation Fund, Cancer Research Horizons and several angel groups also participated.
- The financing supports clinical, engineering and regulatory work for the company's MRI-compatible neurosurgical platform.
Microbot Medical closes $25.2 million preferred-option exercise tranche
- The first closing generated approximately USD 25,200,000 in gross proceeds.
- The transaction involved exercise of outstanding preferred investment options.
- Microbot Medical completed the first closing of preferred investment-option exercises for approximately $25.2 million in gross proceeds, a public-company capital-markets transaction rather than a private funding round.
Microbot Medical receives FDA clearance for LIBERTY endovascular robot
- Microbot Medical received FDA 510(k) clearance for the LIBERTY endovascular robotic system.
- The clearance moved LIBERTY from development into a regulated commercial pathway for endovascular procedures.
- The event anchors Microbot as a surgical robotics pure play with a cleared robotic system.
Stereotaxis receives FDA clearance for MAGiC Sweep catheter
- Stereotaxis received U.S. FDA clearance for MAGiC Sweep, a robotically steered endovascular guide catheter.
- The company described the clearance as its first FDA clearance for an interventional catheter in nearly 20 years.
- The milestone supports the company's robotic magnetic navigation profile with a cleared device update.
EndoQuest Robotics closes Series D-2; filing reports $30.745 million sold
- The company explicitly described the Series D-2 financing as successfully closed.
- Crescent Enterprises and Dr. Fred Moll co-led; Puma Venture Capital and UTHealth Houston also participated.
- A subsequent SEC Form D reported the completed amount sold, separate from the larger total offering target.
Neuralink raises $650 million Series E
- ARK Invest, DFJ Growth, Founders Fund, G42, Human Capital, Lightspeed, QIA, Sequoia Capital, Thrive Capital, Valor Equity Partners and Vy Capital participated.
- Neuralink linked the financing to broader access for people with unmet medical needs and continued brain-interface development.
- At the announcement, Neuralink reported five people with severe paralysis using its technology and clinical trials spanning the United States, Canada and the UAE.
SS Innovations uplists to Nasdaq while scaling SSi Mantra surgical robotics
- SS Innovations announced its uplisting to Nasdaq under ticker SSII.
- The company positioned the listing around its SSi Mantra surgical robotic system and international commercialization plan.
- The event is a public-market milestone for a surgical robotics pure play.
Johnson & Johnson MedTech completes first clinical cases with OTTAVA surgical robot
- Johnson & Johnson MedTech completed the first cases in the clinical trial for the OTTAVA robotic surgical system.
- The first procedure was a Roux-en-Y gastric bypass at Memorial Hermann-Texas Medical Center.
- The milestone moves OTTAVA from platform development into clinical use evidence for soft-tissue robotic surgery.
Andromeda partners with Richard Wolf and Quanta System
- Richard Wolf contributes endoscopic imaging and surgical instrumentation.
- Quanta System contributes holmium laser technology for the HoLEP workflow.
- Andromeda reported 15 completed ASTRA procedures in Chile and New Zealand when it announced the partnerships.
Channel Robotics named finalist for UC San Diego Faculty Startup of the Year
- UC San Diego listed Channel Robotics and co-founder Philip Weissbrod among the finalists for Faculty Startup of the Year in the 2025 Chancellor's Innovation Awards.
- The awards program recognized university innovators shaping commercialization outcomes across healthcare and technology, with more than 50 applications submitted that year.
- The finalist recognition highlighted Channel's flexible endoscopic surgical robotics platform inside UC San Diego's innovation ecosystem.
Noah Medical Galaxy reaches 5,000 U.S. procedures
- Dr. Abhinav Agrawal performed the milestone procedure at Long Island Jewish Medical Center in New Hyde Park, New York.
- The platform integrates tomosynthesis and augmented fluoroscopy with a disposable bronchoscope offering continuous vision.
SS Innovations unveils India's first mobile tele-surgical unit
- SS Innovations unveiled the SSI Mantra Tele-Sync Mobile Unit, known as MantraM, at its March 2025 robotic-surgery conference.
- The mobile unit integrates the SSi Mantra 3 surgical robot with high-speed connectivity to support remote surgery, training and mentoring.
- MantraM is intended to extend specialist robotic-surgery access into remote and underserved locations.
FDA clears MONARCH QUEST robotic-bronchoscopy upgrade
- MONARCH QUEST adds enhanced AI navigation and a verified interface for GE HealthCare’s OEC 3D mobile cone-beam CT imaging system.
- Its NVIDIA RTX accelerated computing stack increases real-time computational power by 260% for navigation algorithms.
- The update combines scope-in-sheath control and continuous vision with intraprocedural 3D imaging for targeting and tool-in-lesion confirmation.
Stryker advances Mako Spine and Shoulder at AAOS 2025
- Mako Spine and Mako Shoulder were described as the latest applications in the SmartRobotics suite.
- Stryker said Mako Spine first cases were completed in October and Mako Shoulder first cases at the end of 2024.
- This is distinct from the existing 2023 Mako Total Knee 2.0 event.
Globus Medical brings ExcelsiusFlex robotic navigation to AAOS 2025
- Globus Medical said it would feature ExcelsiusFlex for total knee arthroplasty at the AAOS annual meeting.
- The repaired row keeps the direct GlobeNewswire source but removes launch overstatement.
Redefine Surgery selected for 2025 MassRobotics Accelerator
- Each selected startup received a $100,000 equity-free grant through the Massachusetts Technology Collaborative.
- Redefine Surgery was selected for a vision system that captures surgery as immersive 3D data for training, collaboration and AI-assisted surgery.
- The three-month programme covered customer discovery, manufacturing, fundraising and team development before an April showcase.
Andromeda completes robotic-assisted HoLEP procedure in Chile
- The procedure used Andromeda's tablet-based interface in the ASTRA clinical study.
- Dr. Cristián Trucco performed the procedure at Universidad Católica in Santiago, Chile.
- The milestone established clinical feasibility without implying commercial availability or regulatory approval.
Neuralink launches CONVOY feasibility study for robotic arm control
- Neuralink received approval and launched CONVOY, a feasibility study extending N1 Implant control to an assistive robotic arm.
- CONVOY is designed to evaluate whether people with paralysis can use the N1 Implant to control external robotic assistance.
- The study expands Neuralink's device-control work from computer interfaces toward physical assistive machines.
EndoQuest submits IDE application for PARADIGM clinical study
- The IDE submission covered a prospective clinical study for robotic colorectal procedures using EndoQuest's flexible platform.
- The event precedes FDA IDE grant and first-human-study execution.
Johnson & Johnson receives FDA IDE approval for OTTAVA robotic surgical system
- Johnson & Johnson MedTech received FDA investigational device exemption approval for OTTAVA.
- The approval allowed the company to begin a U.S. clinical trial of the robotic surgical system.
- The milestone preceded the first completed OTTAVA cases and later FDA submission.
Neuralink receives Health Canada approval for CAN-PRIME Study
- Neuralink received Health Canada approval to launch CAN-PRIME, its first international clinical trial.
- CAN-PRIME extends evaluation of the N1 Implant and R1 Robot system outside the United States.
- The trial studies safety and early effectiveness of Neuralink's implant and surgical robot system.
Neuralink receives FDA Breakthrough Device Designation for Blindsight
- The visual prosthesis program is intended to restore visual perception for people with severe vision loss.
- The designation supports faster development and review but does not represent market approval.
PROCEPT BioRobotics receives FDA clearance for HYDROS robotic system
- PROCEPT BioRobotics received FDA 510(k) clearance for HYDROS, its next-generation robotic system for Aquablation therapy.
- HYDROS extends the company''s urology robotics platform with image-guided planning and treatment workflow updates.
- The regulatory milestone is a core commercial proof point for PROCEPT''s surgical robotics profile.
Globus Medical receives FDA clearance for ExcelsiusFlex orthopedic robot
- Globus Medical received FDA 510(k) clearance for the ExcelsiusFlex orthopedic robot.
- The clearance covers the ExcelsiusFlex robotic navigation platform with a total knee arthroplasty application.
- The approval extends Globus Medical's Excelsius robotics ecosystem from spine and cranial navigation into orthopedic reconstruction.
SSi Mantra surgical robotic system approved for telesurgeries in Indonesia
- • SS Innovations' SSi Mantra Surgical Robotic System received regulatory approval from the Indonesian Ministry of Health for clinical use i...
- • SS Innovations has commenced the regulatory approval process in the United States and the European Union.
- • The company anticipates FDA and CE Mark approvals in 2025.
Zeta Surgical completes first multicenter clinical study of its navigation system
- Fifteen patients requiring elective or emergency ventriculostomy were successfully cannulated in a single attempt, with no adverse events reported.
- The trial took place at Singapore General Hospital and Tan Tock Seng Hospital, led by NNI consultant Dr. Min Wei Chen.
- The system had received FDA 510(k) clearance in January 2024, before this study-completion announcement.
AiM Medical Robotics showcased in MassRobotics 2024 programme cohorts
- AiM Medical Robotics participated in the MassRobotics programme.
- The programme brought robotics companies into a structured accelerator, mentorship or industry-competition setting.
- The company was presented alongside the other cohort members or finalists on the announcement date.
Neuralink reports PRIME Study progress after first human implant
- Neuralink published a progress update on the PRIME Study after the first human implantation.
- The company said the participant was using the implant to control a computer cursor and digital interfaces.
- Neuralink also disclosed that some implant threads had retracted from the brain, reducing electrode effectiveness and prompting software and signal-processing changes.
FDA clears Intuitive da Vinci 5
- The system introduced optional Force Feedback instruments and a redesigned console.
- Intuitive described more than 150 system enhancements and expanded computing capacity.
- Initial U.S. availability was limited to selected customers before broader commercial introduction.
Zimmer Biomet receives FDA clearance for ROSA Shoulder System
- Zimmer Biomet received U.S. FDA clearance for the ROSA Shoulder System.
- The company described ROSA Shoulder as the first robotic assistant for shoulder replacement surgery.
- The clearance expands Zimmer Biomet's ROSA robotics portfolio from knee and hip into shoulder arthroplasty.
MMI completes Series C financing led by Fidelity
- All existing investors participated in the financing.
- The capital was allocated to high-growth-market commercialization, indication-expansion studies, advanced technology and global operations.
- The round extended the company’s funding base for microsurgery product and market expansion.
Neuralink reports first human implant in PRIME Study
- Neuralink announced that the first human participant had received its brain-computer interface implant.
- The PRIME Study evaluates both the wireless implant and the surgical robot used for implantation.
- The milestone marked Neuralink's first human use of its implantable BCI system.
Noah Medical Galaxy reaches 500 U.S. procedures
- Dr. Krish Bhadra performed the milestone procedure.
- CHI Memorial was the first hospital in Tennessee to adopt Galaxy, which combines TiLT+ imaging with a single-use bronchoscope.
EndoQuest and OMNIVISION partner on image sensor for Flexible Robotic System
- The partnership tied OMNIVISION imaging hardware to EndoQuest’s flexible robotic surgery system rather than a broad supplier arrangement.
- EndoQuest highlighted visualization as part of the system’s endoluminal procedure workflow.
- OMNIVISION’s imaging sensor was selected as an integrated component of the named Flexible Robotic System.
EndoQuest Flexible Robotic System enters FDA Safer Technologies Program
- The StEP acceptance applied to EndoQuest's flexible robotic system for endoluminal surgery, not to a general company milestone.
- FDA's Safer Technologies Program is intended to speed review interactions for devices expected to improve safety over available approaches.
- The event is regulatory pathway progress; it is not a clearance, approval or commercial deployment.
Noah Medical begins Galaxy clinical trial in Hong Kong
- Drs. Calvin Ng and Rainbow Lau conducted the first procedure.
- The trial evaluates TiLT+ imaging, center-strike accuracy and diagnostic yield; patients were enrolled and the trial was underway.
EndoQuest raises $42M C-1 financing for endoluminal robotics
- The C-1 round was led by CE Ventures Limited and McNair Interests Ltd., with Puma Venture Capital joining as a new investor.
- EndoQuest said the capital would support technology development, regulatory progress and commercialization of its flexible robotic system.
Neuralink opens recruitment for first-in-human PRIME Study
- Neuralink opened recruitment for its first-in-human PRIME Study at its first hospital site.
- The study targets people with quadriplegia due to cervical spinal cord injury or amyotrophic lateral sclerosis.
- Neuralink described the study as evaluating the investigational N1 Implant and R1 Robot system.
Andromeda Surgical announces autonomous-surgery development platform
- The launch described an AI-assisted platform intended for high-volume surgical procedures.
- The company said it was starting with a urologic procedure while building the robot.
- The source describes a development programme, not a commercially available or regulator-cleared system.
Noah Medical begins U.S. commercial use of Galaxy at UChicago Medicine
- The milestone followed a first-in-human trial at Macquarie University Hospital in Sydney.
- Galaxy combines TiLT+ imaging, a single-use bronchoscope and a compact footprint for bronchoscopy suites.
Neuralink receives FDA approval to launch first-in-human PRIME Study
- Neuralink received FDA approval in May 2023 to launch its first-in-human PRIME Study.
- The study evaluates the safety and initial effectiveness of the N1 Implant and R1 surgical robot system for people with paralysis.
- The approval moved Neuralink from preclinical development into human clinical testing for its implantable brain-computer interface.
Noah Medical raises $150M Series B for endoluminal robotics
- Tiger Global and eight named existing investors joined the oversubscribed financing alongside undisclosed strategic investors.
- Galaxy had received FDA clearance for U.S. commercial use and begun first-in-human trials at Macquarie University Hospital in Sydney.
- The system combines TiLT+ tomosynthesis and augmented fluoroscopy with a single-use bronchoscope for lung-nodule diagnosis.
EndoQuest and Proximie partner on digital surgery support for ELS
- The partnership linked EndoQuest's endoluminal robotic surgery platform with Proximie's digital surgery and remote collaboration infrastructure.
- The companies framed the work around education, procedural support and connected operating-room workflows for ELS use.
- This is a platform-enablement partnership rather than a deployment or regulatory clearance.
Noah Medical begins first-human Galaxy trial in Sydney
- The FRONTIER study evaluates safety and feasibility for reaching and biopsying peripheral lung nodules.
- Professor Alvin Ing is the principal investigator; the trial uses integrated tomosynthesis, augmented fluoroscopy and a single-use bronchoscope.